Ulcerative colitis-associated cancer and its prevention
Ulcerative colitis-associated cancer and its prevention
批准号:
7118000
负责人:
Guang-Yu Yang
金额:
$23.31万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2009-05-31
关键词:
DNA damageN glycosidaseNAD(P)H dehydrogenaseacetylcysteineangiogenesisantioxidantscancer preventioncarcinogenesiscell proliferationchemopreventiondisease /disorder modeldrug screening /evaluationenzyme activityenzyme inhibitorsgenetically modified animalsinflammationlaboratory mouseleukocytesleukotrieneslipoxygenasenitric oxide synthaseoxidative stresspathologic processprostaglandin Eprostaglandin endoperoxide synthasetocopherols
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of this project is to provide a mechanistic basis for the prevention of Ulcerative colitis (UC)-associated carcinogenesis (UC-Ca). Our unique UC-Ca mouse model will be used to test the hypothesis that leukocyte-NADPH oxidase and endothelial nitric oxide synthase (eNOS) play central roles in UC-Ca by driving nitro-oxidative stress-caused genetic damage and angiogenesis, and by causing cell hyperproliferation via the overproduction of prostaglandin E2 (PGE2) and Leukotriene B4 (LTB4), with the following specific aims:
1. To study the role of leukocyte-generated oxidative stress and associated DNA damage in UC-Ca by using gp91phox (leukocyte NADPH oxidase) and Ogg1 (8-hydroxydeoxyguanine DNA glycosylase) deficient mice. We will test the hypothesis that gp91phox is vital for causing oxidative DNA damage and UC-Ca, and that Ogg1 protects from UC-Ca, using gene knockout mice in the UC-Ca model.
2. To test the hypothesis that eNOS plays a key role in UC-Ca by driving nitro-oxidative stress-caused DNA damage and by promoting angiogenesis, iNOS deficient mice exhibited no difference in susceptibility to UC-Ca or nitrotyrosine formation in our model, but eNOS was expressed in active inflammatory cells. The roles of eNOS or both eNOS/iNOS in UC-Ca will be studied using an eNOS (-/-)mice and the non-selective NOS inhibitor aminoguanidine.
3. To test the hypothesis that inflammation-induced LTB4 and PGE2 overproduction contributes to UCCa by studying the effect of the combination of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5- LOX) inhibitors. COX-2 inhibition exacerbates UC, possibly via the shunting of arachidonic acid substrate to the LTB4 pathway and increasing inflammatory injury. The combination of 5-LOX- and COX-2-specific inhibitors may overcome this problem in the treatment of UC patients. This concept will be tested in our UC-Ca model.
4. To determine the effectiveness of water-soluble and lipid-soluble antioxidants and their combination as a chemopreventive approach against UC-Ca in wild type and Ogg1(-/-) mice. The combination of vitamin E and N-acetylcysteine (NAC) may exert synergistic or additive effects against nitro-oxidative stress, inflammation, and UC-Ca. This concept will be investigated using our UC-Ca model as well as using Ogg1 knockout mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Omega-3 derived epoxy fatty acids and sEH in pancreatitis-induced carcinogenesis
-
批准号:9253390
-
项目类别:
-
资助金额:$48.18万
-
财政年份:2016
-
负责人:Guang-Yu Yang
-
依托单位:
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH
-
批准号:8840908
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2013
-
负责人:Guang-Yu Yang
-
依托单位:
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH
-
批准号:8683133
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2013
-
负责人:Guang-Yu Yang
-
依托单位:
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH
-
批准号:8576766
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2013
-
负责人:Guang-Yu Yang
-
依托单位:
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH
-
批准号:9056497
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2013
-
负责人:Guang-Yu Yang
-
依托单位:
Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis
-
批准号:8220421
-
项目类别:
-
资助金额:$33.1万
-
财政年份:2012
-
负责人:Guang-Yu Yang
-
依托单位:
Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis
-
批准号:9093761
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2012
-
负责人:Guang-Yu Yang
-
依托单位:
Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis
-
批准号:8862423
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2012
-
负责人:Guang-Yu Yang
-
依托单位:
Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis
-
批准号:8527744
-
项目类别:
-
资助金额:$30.43万
-
财政年份:2012
-
负责人:Guang-Yu Yang
-
依托单位:
Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis
-
批准号:8682793
-
项目类别:
-
资助金额:$31.09万
-
财政年份:2012
-
负责人:Guang-Yu Yang
-
依托单位:
Soluble epoxide hydrolase as a novel target of colitis-induced carcinogenesis
-
批准号:8309390
-
项目类别:
-
资助金额:$30.41万
-
财政年份:2009
-
负责人:Guang-Yu Yang
-
依托单位:
Soluble epoxide hydrolase as a novel target of colitis-induced carcinogenesis
-
批准号:8193228
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2009
-
负责人:Guang-Yu Yang
-
依托单位:
Soluble epoxide hydrolase as a novel target of colitis-induced carcinogenesis
-
批准号:7730989
-
项目类别:
-
资助金额:$32.62万
-
财政年份:2009
-
负责人:Guang-Yu Yang
-
依托单位:
HMG-CoA reductase inhibitor, tea polyphenols and pancreatic cancer prevention
-
批准号:7257549
-
项目类别:
-
资助金额:$12.08万
-
财政年份:2007
-
负责人:Guang-Yu Yang
-
依托单位:
HMG-CoA reductase inhibitor, tea polyphenols and pancreatic cancer prevention
-
批准号:7434507
-
项目类别:
-
资助金额:$21.14万
-
财政年份:2007
-
负责人:Guang-Yu Yang
-
依托单位:
Ulcerative colitis-associated cancer and its prevention
-
批准号:7106997
-
项目类别:
-
资助金额:$23.87万
-
财政年份:2004
-
负责人:Guang-Yu Yang
-
依托单位:
Ulcerative colitis-associated cancer and its prevention
-
批准号:6828434
-
项目类别:
-
资助金额:$25.05万
-
财政年份:2004
-
负责人:Guang-Yu Yang
-
依托单位:
Ulcerative colitis-associated cancer and its prevention
-
批准号:7430444
-
项目类别:
-
资助金额:$21.68万
-
财政年份:2004
-
负责人:Guang-Yu Yang
-
依托单位:
Ulcerative colitis-associated cancer and its prevention
-
批准号:7256524
-
项目类别:
-
资助金额:$21.68万
-
财政年份:2004
-
负责人:Guang-Yu Yang
-
依托单位:
Mouse Histology and Phenotyping Laboratory Shared Resource
-
批准号:10902183
-
项目类别:
-
资助金额:$14.13万
-
财政年份:1997
-
负责人:Guang-Yu Yang
-
依托单位: